関連する実験動画
Updated: Jul 26, 2026
09:58
Lipidomics and Transcriptomics in Neurological Diseases
Published on: March 18, 2022
カワサキ症候群の後の脂質プロフィールの変化
J W Newburger1, J C Burns, A S Beiser
1Department of Cardiology, Children's Hospital, Boston, MA 02115.
Circulation
|August 1, 1991
まとめ
川崎症候群は子供の脂質レベルに影響し,特に高密度脂質タンパク質コレステロールを長期的に低下させる. これらの患者の心血管疾患リスクを管理するために,継続的なモニタリングが不可欠です.
科学分野:
- ペディアトリック・カルディオロジー
- 脂質代謝についてです.
- 川崎病の研究について
背景:
- 川崎病 (KD) は子供に影響を与え,冠動脈への嗜好を持っています.
- KD後の脂質プロファイルの評価は,長期的な心血管の健康に不可欠です.
- 脂質異常を理解することは,潜在的な合併症の予測と管理に役立ちます.
研究 の 目的:
- カワサキ症候群の後の子供の脂質代謝異常を調査するために.
- 総コレステロール,HDLコレステロール,トリグリセリドの変化を時間とともに追跡する.
- KD患者の脂質レベルを両親と比較し,冠動脈異常との相関を評価する.
主な方法:
- 血の総コレステロール,HDLコレステロール,トリグリセリドの血濃度を測定した.
- カワサキ症候群の既往歴のある105人の患者に酵素療法を使用した.
- 測定は,急性期から病後3年以上までの6つの異なる時間間隔にわたって行われました.
主要な成果:
- トータルコレステロールは最初は低下したが,回復後の正常化.
- 高密度脂質タンパク質 (HDL) コレステロールは,最新の間隔でも,長期的には予想より著しく低いままでした.
- トリグリセリド濃度は当初高かったが,統計的に有意ではないが,時間とともに低下した.
- KD患者は,親と比較して,同様の総コレステロールを示したが,著しく低いHDLコレステロールを示した.
- HDLコレステロールのレベルを下げる傾向があり,KD患者の慢性冠動脈異常が続いている.
結論:
- 川崎症候群は,脂質代謝の顕著で長期的な異常と関連しています.
- 異常な脂質プロファイル,特に低下したHDLコレステロールは,臨床回復後も長く持続します.
- KDの生存者における脂質レベルの長期監視は,心血管リスクと動脈硬化症の発達を監視するために不可欠です.
関連する概念動画
01:38Inflammation
Overview
01:31Lipid-derived Compounds in the Human Body
Fats and lipids are crucial components in the human body. Some lipid-derived compounds, such as fat-soluble vitamins, eicosanoids, lipoproteins, and glycolipids, also play unique roles to support various biological processes .
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin, delayed...
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin, delayed...
01:24Overview of Lipid Metabolism
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
01:25Blood Studies for Cardiovascular System III: Serum Lipid Profile
Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
01:19Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...